Scaffold Technology Market size was valued at USD 1.5 billion in 2023 and is predicted to cross USD 5.1 billion by the end of 2036, growing at a CAGR of 10.7% during the forecast period, i.e., 2024-2036. In 2024, the industry size of scaffold technology is estimated at USD 1.6 billion.
Globally, there has been an increasing demand for reconstruction surgeries such as cleft lip, cleft palate, breast reduction surgery, oculoplasty, and abdominoplasty, influencing the scaffold technology market growth. According to a report by the International Society of Aesthetic Plastic Surgery (ISAPS) in September 2023, plastic surgeries increased by 11.2% compared to 2022 data. These include 14.9 million and 18.8 million surgical and non-surgical procedures respectively. Moreover, aesthetic surgeries witnessed a gain of 41.3% since 2019.
Growth Drivers
Challenges
Base Year |
2023 |
Forecast Year |
2024-2036 |
CAGR |
10.7% |
Base Year Market Size (2023) |
USD 1.5 billion |
Forecast Year Market Size (2036) |
USD 5.1 billion |
Regional Scope |
|
Type (Hydrogels, Micropatterned Surface Microplates, Nanofiber Based Scaffolds)
The hydrogels segment in the scaffold technology market is poised to capture a share of 40.2% in the coming years, impacting the sector's scaffold technology landscape. Significant growth in the revenue share is anticipated owing to the properties it offers while using it such as easy drug and cell loading for controlled drug delivery. Moreover, the advanced technologies in this field support the market growth. For instance, in March 2021, Bio-Techne Corporation released Cultrex UltiMatrix for culturing pluripotent stem cells as they slow down the Basement Membrane Extract (BME) growth factor. It is a cutting-edge matrix hydrogel with enhanced tensile strength and the ideal extracellular matrix protein composition for regenerative medicine, personalized medicine, and drug discovery studies. Growth in this sector will boost the drug delivery devices value in the near future.
Application (Stem Cell Therapy, Tissue Engineering & Regenerative Medicine, Drug Discover)
The stem cell therapy, tissue engineering & regenerative medicine segment is expected to be the fastest-growing segment with a lucrative size by the end of the forecast period. This growth is propelled by the increased usage of scaffolding technologies in colorectal procedures, reconstruction and aesthetic surgeries, tumor repair, soft tissue, and periodontology. Furthermore, researchers have been highly attracted to the diverse use of scaffold technology in the field of regenerative medicine in recent years. In addition, a German biotech company Co. don AG, was fully acquired by ReLive Biotechnologies, Ltd in Jan 2023. Credited to this, ReLive was able to carry out independent research and create affordable tissue-engineered products using 3D printing and stem cell technology.
Our in-depth analysis of the global market includes the following segments:
Type |
|
Application |
|
End User |
|
Disease Type |
|
North America Market Statistics
The scaffold technology market in North America is projected to hold the largest size of USD 852.4 million during the forecast period. The growth in this region is poised due to the latest advancements in regenerative medicine and stem cell research. According to a report by the National Library of Medicine in 2023, stem cell revenue share in 2022 was about USD 297 million and is propelled to observe a growth rate of 16.8% till 2027. This is led by various factors such as clinical trials with positive results along with high demand for regenerative medicine.
The increasing funding for regenerative medicine and stem cell research in the U.S. from the government and various private institutions. For instance, the California Institute for Regenerative Medicine (CIRM), awarded USD 43.8 million in funds for enhancing gene and stem cell therapy in California. Additionally, it is estimated that the state of California will fund an amount of USD 110 million from 2024 to 2028 for research studies.
There is a presence of prominent players in Canada who are launching and promoting new products for the development of scaffold technologies, such as STEMCELL Technologies, BlueRock Therapeutics, Ontario Institute for Regenerative Medicine, and many more. The presence of such key players will augment the stem cell treatment market share in the forecast period.
APAC Market Analysis
Asia Pacific will also encounter huge growth in the scaffold technology market share during the forecast period with a notable size and will account for the second position. The latest innovations and production of various techniques are expected to propel the development of scaffold technologies in this region. Gelomics, an Australian company collaborated with Rousselot Biomedical in October 2023, regarding the supply of Rousselot X-Pure GelMA (gelatin methacryloyl) for using it as an extracellular matrix in tissue culture systems.
The increasing advancements in stem cells are fueled to act as a growth factor for scaffold techniques in China. In November 2022, more than 31000 hematopoietic stem cell transplantations (HSCTs) were done between 2020 and 2021 and reported to the Chinese Blood and Marrow Transplantation Registry Group.
Using state-of-the-art techniques in Japan for creating more precise artificial scaffolds is at a surge. According to a report in October 2021, the Okinawa Institute of Science and Technology Graduate University (OIST) uses a 3D scaffold that can guide while regenerating neurons in a particular direction.
Scaffold technology market growth is predicted that these companies will occupy a tremendous share. Most of these companies are continuously collaborating, adopting M&A, and expanding their global footprint, for the growth of this industry using 3D cell culture and artificial scaffold materials such as collagen and gel and are set to be the major key players in this sector.
Some of the key players include:
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?